Overview from the Chair
As chair of the Kolling Institute Governance Committee, I have been fortunate to witness the steady improvements at the Kolling in recent years, and particularly in 2022. Our large and experienced team of researchers is well placed to expand its research activity and increase its impact on the national and international stage.
I am tremendously proud of our unique group of researchers, and consistently impressed by their unrelenting commitment to quality research, new models of care and better health outcomes. In some cases, these improvements can be life-changing. Many of our researchers are juggling clinical and research responsibilities, while making substantial inroads in their individual areas of expertise. In 2022, it was pleasing to see the consistent progress with the implementation of the Kolling’s five-year Research Strategy. This progress has only been possible with the support of a large number of people who have shared their time and experience to help secure the Kolling’s future success. The strategy leverages the collective strengths of our joint venture partners the University of Sydney and the Northern Sydney Local Health District, who both share a vision for excellence in translational research. I would like to extend my thanks to Deb Willcox, former NSLHD Chief Executive, who in collaboration with Professor Robyn Ward, Executive Dean and Pro Vice-Chancellor (Medicine and Health) at the University of Sydney, pioneered new ways to strengthen the long-standing partnership and build on our culture of trust and transparency to enable strategic use of resources and improved funding for researchers. The Kolling kicked goals in so many areas over the year, from new infrastructure improvements to substantial grants and prestigious accolades. Researchers were supported with better structures, a stronger culture of collaboration, as well as practical support and training. All these components have increased opportunities for scientific progress and research impact. In 2022, there was a changing of the guard with Professor Carolyn Sue stepping down from her role as Executive Director of the Kolling Institute and Professor Jim Elliott appointed the Kolling’s first
Academic Director. I would like to thank Carolyn for her remarkable contribution to the institute over more than two decades, and particularly over the last five years as Executive Director. The Kolling benefitted from a smooth transition to a new leader and I would like to acknowledge Professor Elliott’s commitment to the implementation of the research strategy and the Kolling’s ongoing success. As a globally respected researcher, Jim has brought tremendous knowledge, experience and expertise to his new role, and we look forward to him building on the wonderful work already achieved. As we mark the end of a successful year, I would like to express my gratitude to our joint venture partners for their continued support. Without the financial and institutional backing of the University of Sydney and the Northern Sydney Local Health District, the Kolling and its researchers would not be in the strong position they are today. Michael Nugent Chair Kolling Institute Governance Committee
6
Kolling Institute Year in Review 2022
Made with FlippingBook - professional solution for displaying marketing and sales documents online